Literature DB >> 6364463

Naloxone administration to patients with acute stroke.

J Jabaily, J N Davis.   

Abstract

Naloxone, an opiate antagonist, has recently been reported to temporarily reverse neurologic deficits associated with subarachnoid hemorrhage. To determine if this unexpected effect of naloxone might also occur in other forms of cerebrovascular diseases, 13 patients who presented with acute neurologic deficits were administered intravenous naloxone. In 3 of these patients, coincidental improvement in neurologic status was seen. In one patient the improvement was permanent. Ten of the 11 patients with non fatal neurologic damage improved later in their hospital course--7 of them to their pre-admission state. The only side effect noted was the temporally related onset of a single focal seizure in an ethanol intoxicated patient with an intracerebral hemorrhage.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6364463     DOI: 10.1161/01.str.15.1.36

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  8 in total

Review 1.  Clinical trials for cytoprotection in stroke.

Authors:  Lise A Labiche; James C Grotta
Journal:  NeuroRx       Date:  2004-01

Review 2.  Opioid antagonists as potential therapeutics for ischemic stroke.

Authors:  Nadia Peyravian; Emre Dikici; Sapna Deo; Michal Toborek; Sylvia Daunert
Journal:  Prog Neurobiol       Date:  2019-08-06       Impact factor: 11.685

3.  A double blind randomized pilot trial of naloxone in the treatment of acute ischemic stroke.

Authors:  F Federico; V Lucivero; P Lamberti; A Fiore; C Conte
Journal:  Ital J Neurol Sci       Date:  1991-12

4.  CSF-endorphines in acute and chronic brain lesions.

Authors:  E Hamel
Journal:  Neurosurg Rev       Date:  1988       Impact factor: 3.042

5.  Left-Right Side-Specific Neuropeptide Mechanism Mediates Contralateral Responses to a Unilateral Brain Injury.

Authors:  Hiroyuki Watanabe; Olga Nosova; Daniil Sarkisyan; Marlene Storm Andersen; Liliana Carvalho; Vladimir Galatenko; Igor Bazov; Nikolay Lukoyanov; Gisela H Maia; Mathias Hallberg; Mengliang Zhang; Jens Schouenborg; Georgy Bakalkin
Journal:  eNeuro       Date:  2021-05-25

6.  Ipsilesional versus contralesional postural deficits induced by unilateral brain trauma: a side reversal by opioid mechanism.

Authors:  Hiroyuki Watanabe; Olga Nosova; Daniil Sarkisyan; Marlene Storm Andersen; Mengliang Zhang; Linda Rorick-Kehn; Fredrik Clausen; Kinga Gawel; Jan Kehr; Mathias Hallberg; Jens Schouenborg; Niklas Marklund; Georgy Bakalkin
Journal:  Brain Commun       Date:  2020-12-13

Review 7.  The left-right side-specific endocrine signaling in the effects of brain lesions: questioning of the neurological dogma.

Authors:  Georgy Bakalkin
Journal:  Cell Mol Life Sci       Date:  2022-10-11       Impact factor: 9.207

8.  Post-stroke Intranasal (+)-Naloxone Delivery Reduces Microglial Activation and Improves Behavioral Recovery from Ischemic Injury.

Authors:  Jenni E Anttila; Katrina Albert; Emily S Wires; Kert Mätlik; Lisa C Loram; Linda R Watkins; Kenner C Rice; Yun Wang; Brandon K Harvey; Mikko Airavaara
Journal:  eNeuro       Date:  2018-04-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.